Skip to content
Study details
Enrolling now

Geniculate Artery Embolization for Osteoarthritis

University of Minnesota
NCT IDNCT04456569ClinicalTrials.gov data as of Apr 2026
Target enrollment

20

Study length

about 4 years

Ages

40–70

Locations

1 site in MN

What this study is about

This trial is testing geniculate artery embolization as a treatment for osteoarthritis. This pilot trial will compare geniculate artery embolization to standard of care (physical therapy and oral anti-inflammatory medications) in patients with mild to moderate knee OA. The goal is to determine if embolotherapy can provide sustained symptom control and modify disease progression.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Use Geniculate Artery Embolization

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Standard

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Endpoints

Primary: Safety as Assessed by Grade 3-4 Adverse events

Secondary: C-Reactive Protein Concentration, IL-6 Concentration

Body systems

Musculoskeletal